Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (101-110 of 241) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|October 31, 2015
Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infectionMolebogeng X Rangaka, Solange C Cavalcante, Ben J Marais, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2006
Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adultsJean B Nachega, Michael Hislop, David W Dowdy, et al.
AIDS Patient Care and Stds|February 5, 2013
Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adultsMonique M Duwell, Amy R Knowlton, Jean B Nachega, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative studyJean B Nachega, Amy R Knowlton, Andrea Deluca, et al.
AIDS (London, England)|October 22, 2019
CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIVLelia H Chaisson, Valeria Saraceni, Silvia Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2019
Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso CohortNicole Salazar-Austin, Silvia Cohn, Sanjay Lala, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug usersJonathan E Golub, Jacquie Astemborski, Mohammed Ahmed, et al.
The Lancet. HIV|March 27, 2025
Tuberculosis disease among people with HIV: therapeutic advancesVidya Mave, Mandar Paradkar, Francesca Conradie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapyLaura Aian Gillini, Antonella Cingolani, Rita Murri, et al.
Antimicrobial Agents and Chemotherapy|April 3, 2019
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of TuberculosisVikram Saini, Nicole C Ammerman, Yong Seok Chang, et al.
Pageof 25

Showing results (101-110 of 241) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|October 31, 2015
Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infectionMolebogeng X Rangaka, Solange C Cavalcante, Ben J Marais, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2006
Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adultsJean B Nachega, Michael Hislop, David W Dowdy, et al.
AIDS Patient Care and Stds|February 5, 2013
Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adultsMonique M Duwell, Amy R Knowlton, Jean B Nachega, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative studyJean B Nachega, Amy R Knowlton, Andrea Deluca, et al.
AIDS (London, England)|October 22, 2019
CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIVLelia H Chaisson, Valeria Saraceni, Silvia Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2019
Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso CohortNicole Salazar-Austin, Silvia Cohn, Sanjay Lala, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug usersJonathan E Golub, Jacquie Astemborski, Mohammed Ahmed, et al.
The Lancet. HIV|March 27, 2025
Tuberculosis disease among people with HIV: therapeutic advancesVidya Mave, Mandar Paradkar, Francesca Conradie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapyLaura Aian Gillini, Antonella Cingolani, Rita Murri, et al.
Antimicrobial Agents and Chemotherapy|April 3, 2019
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of TuberculosisVikram Saini, Nicole C Ammerman, Yong Seok Chang, et al.
Pageof 25